Principal Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51B Buy
1,255,719
+29,020
+2% +$29.7M 0.74% 25
2026
Q1
$1.13B Sell
1,226,699
-42,832
-3% -$43.4M 0.6% 33
2025
Q4
$1.36B Buy
1,269,531
+15,840
+1% +$15.1M 0.7% 26
2025
Q3
$957M Buy
1,253,691
+11,954
+1% +$8.9M 0.48% 41
2025
Q2
$968M Sell
1,241,737
-42,557
-3% -$33.1M 0.51% 40
2025
Q1
$1.06B Sell
1,284,294
-7,164
-0.6% -$5.96M 0.6% 34
2024
Q4
$997M Buy
1,291,458
+82,913
+7% +$68.7M 0.54% 38
2024
Q3
$1.07B Buy
1,208,545
+60,306
+5% +$54.2M 0.58% 34
2024
Q2
$1.04B Sell
1,148,239
-69,326
-6% -$55.5M 0.62% 31
2024
Q1
$947M Sell
1,217,565
-6,569
-0.5% -$4.67M 0.56% 31
2023
Q4
$714M Sell
1,224,134
-23,177
-2% -$13.5M 0.46% 47
2023
Q3
$670M Buy
1,247,311
+7,494
+0.6% +$3.86M 0.48% 44
2023
Q2
$581M Sell
1,239,817
-12,227
-1% -$5.13M 0.4% 54
2023
Q1
$430M Sell
1,252,044
-52,648
-4% -$17.8M 0.31% 82
2022
Q4
$477M Sell
1,304,692
-30,725
-2% -$10.9M 0.36% 64
2022
Q3
$432M Buy
1,335,417
+59,876
+5% +$19M 0.34% 70
2022
Q2
$414M Sell
1,275,541
-160,986
-11% -$48.3M 0.31% 79
2022
Q1
$411M Sell
1,436,527
-19,096
-1% -$4.91M 0.26% 98
2021
Q4
$402M Buy
1,455,623
+28,315
+2% +$7.18M 0.24% 113
2021
Q3
$330M Buy
1,427,308
+95,767
+7% +$23.6M 0.22% 118
2021
Q2
$306M Buy
1,331,541
+57,769
+5% +$11.6M 0.2% 128
2021
Q1
$238M Sell
1,273,772
-16,396
-1% -$3.21M 0.17% 149
2020
Q4
$218M Sell
1,290,168
-153,948
-11% -$23M 0.16% 151
2020
Q3
$214M Sell
1,444,116
-114,029
-7% -$17.6M 0.18% 141
2020
Q2
$256M Buy
1,558,145
+319,133
+26% +$49M 0.23% 120
2020
Q1
$172M Buy
1,239,012
+33,312
+3% +$4.58M 0.19% 140
2019
Q4
$158M Sell
1,205,700
-253,011
-17% -$29.3M 0.13% 195
2019
Q3
$163M Sell
1,458,711
-52,545
-3% -$5.85M 0.14% 186
2019
Q2
$167M Sell
1,511,256
-41,646
-3% -$4.9M 0.15% 169
2019
Q1
$202M Sell
1,552,902
-182,092
-10% -$22.1M 0.19% 132
2018
Q4
$201M Buy
1,734,994
+255,461
+17% +$28.5M 0.21% 114
2018
Q3
$159M Buy
1,479,533
+34,935
+2% +$3.49M 0.14% 176
2018
Q2
$123M Sell
1,444,598
-363,349
-20% -$29.8M 0.11% 211
2018
Q1
$140M Buy
1,807,947
+138,746
+8% +$11.2M 0.13% 192
2017
Q4
$141M Buy
1,669,201
+177,006
+12% +$15.1M 0.13% 209
2017
Q3
$128M Sell
1,492,195
-77,300
-5% -$6.34M 0.12% 212
2017
Q2
$129M Buy
1,569,495
+146,037
+10% +$11.9M 0.13% 207
2017
Q1
$120M Buy
1,423,458
+22,988
+2% +$1.84M 0.14% 161
2016
Q4
$103M Sell
1,400,470
-49,872
-3% -$3.71M 0.13% 171
2016
Q3
$116M Buy
1,450,342
+19,696
+1% +$1.58M 0.15% 147
2016
Q2
$113M Sell
1,430,646
-62,497
-4% -$4.71M 0.16% 152
2016
Q1
$108M Sell
1,493,143
-31,766
-2% -$2.4M 0.16% 152
2015
Q4
$128M Buy
1,524,909
+188,217
+14% +$15.6M 0.19% 137
2015
Q3
$112M Buy
1,336,692
+33,686
+3% +$2.84M 0.18% 152
2015
Q2
$109M Sell
1,303,006
-162,293
-11% -$12.4M 0.16% 170
2015
Q1
$106M Sell
1,465,299
-59,543
-4% -$4.24M 0.16% 176
2014
Q4
$105M Sell
1,524,842
-154,731
-9% -$10.4M 0.16% 174
2014
Q3
$109M Buy
1,679,573
+11,141
+0.7% +$705K 0.18% 151
2014
Q2
$104M Buy
1,668,432
+316,798
+23% +$18.9M 0.17% 156
2014
Q1
$79.6M Buy
1,351,634
+197,646
+17% +$11M 0.14% 195
2013
Q4
$58.9M Sell
1,153,988
-2,630,004
-70% -$132M 0.11% 237
2013
Q3
$190M Buy
3,783,992
+363,807
+11% +$19M 0.39% 40
2013
Q2
$168M Buy
+3,420,185
New +$186M 0.37% 44

Other funds holding LLY

Principal Financial Group's LLY Position: Q2 2026 in Review

Principal Financial Group increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $29.7M and bringing the position to 1,255,719 shares worth $1.51B. The position accounts for 0.74% of the portfolio, ranked #25.

Principal Financial Group first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Principal Financial Group held 1,255,719 shares of Eli Lilly worth $1.51B as of Q2 2026.
  • Principal Financial Group bought 29,020 Eli Lilly shares in Q2 2026, an estimated $29.7M.
  • Eli Lilly made up 0.74% of Principal Financial Group's portfolio in Q2 2026, its #25 holding.
  • Principal Financial Group first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.